Credit Suisse Ag Sutro Biopharma, Inc. Transaction History

Credit Suisse Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$5.41 - $8.08 $1,487 - $2,222	-275 Reduced 99.28%	2 $0
Q3 2022 Nov 10, 2022	BUY	$5.17 - $7.11 $1,178 - $1,621	228 Added 465.31%	277 $2,000
Q2 2022 Aug 12, 2022	SELL	$3.41 - $8.95 $92,492 - $242,759	-27,124 Reduced 99.82%	49 $0
Q1 2022 May 16, 2022	SELL	$7.78 - $15.31 $8,861 - $17,438	-1,139 Reduced 4.02%	27,173 $223,000
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $105,122 - $173,580	7,377 Added 35.24%	28,312 $421,000
Q3 2021 Nov 12, 2021	BUY	$16.88 - $22.38 $27,818 - $36,882	1,648 Added 8.54%	20,935 $396,000
Q2 2021 Aug 16, 2021	BUY	$18.03 - $23.82 $347,744 - $459,416	19,287 New	19,287 $358,000
Q1 2021 May 14, 2021	SELL	$20.29 - $27.54 $584,088 - $792,793	-28,787 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$10.16 - $23.98 $292,475 - $690,312	28,787 New	28,787 $625,000

136

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $131M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.